MedTrace Logo

A Randomized, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder.

NCT06037668 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2025-03-12

Study results available
· View outcomes & findings →

Summary

This study is to compare two Virtual Reality (VR)-based interventions, BVR-100 and BES-100, for the treatment of Social Anxiety Disorder (SAD).

Conditions

  • Social Anxiety Disorder (SAD)

Interventions

DEVICE

BVR-100

Experimental self-guided VR intervention for the treatment of SAD

DEVICE

BES-100

Active at-home VR intervention comparator

Sponsors & Collaborators

  • BehaVR LLC

    collaborator INDUSTRY

  • Sumitomo Pharma America, Inc.

    lead INDUSTRY

Principal Investigators

  • Robert Hayes, PhD · Sumitomo Pharma America, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-08
Primary Completion
2023-12-22
Completion
2024-01-10
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06037668 on ClinicalTrials.gov